Abbott Laboratories (BCBA:ABT)

Abbott Laboratories Statistics

Total Valuation

BCBA:ABT has a market cap or net worth of ARS 300.39 trillion. The enterprise value is 308.82 trillion.

Market Cap	300.39T
Enterprise Value	308.82T

Important Dates

The next estimated earnings date is Wednesday, October 15, 2025.

Earnings Date	Oct 15, 2025
Ex-Dividend Date	Jul 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.73B

Valuation Ratios

The trailing PE ratio is 18.10 and the forward PE ratio is 24.01.

PE Ratio	18.10
Forward PE	24.01
PS Ratio	5.85
PB Ratio	4.96
P/TBV Ratio	12.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.98, with an EV/FCF ratio of 38.25.

EV / Earnings	18.61
EV / Sales	5.48
EV / EBITDA	19.98
EV / EBIT	28.42
EV / FCF	38.25

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.27.

Current Ratio	1.82
Quick Ratio	1.14
Debt / Equity	0.27
Debt / EBITDA	1.14
Debt / FCF	1.99
Interest Coverage	15.68

Financial Efficiency

Return on equity (ROE) is 30.93% and return on invested capital (ROIC) is 8.75%.

Return on Equity (ROE)	30.93%
Return on Assets (ROA)	6.62%
Return on Invested Capital (ROIC)	8.75%
Return on Capital Employed (ROCE)	11.78%
Revenue Per Employee	450.64M
Profits Per Employee	145.60M
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.74

Taxes

Income Tax	-7,246.73B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.20%
50-Day Moving Average	41,563.50
200-Day Moving Average	38,193.13
Relative Strength Index (RSI)	58.14
Average Volume (20 Days)	713

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.83

Income Statement

In the last 12 months, BCBA:ABT had revenue of ARS 51.37 trillion and earned 16.60 trillion in profits. Earnings per share was 9,500.38.

Revenue	51.37T
Gross Profit	28.93T
Operating Income	9.91T
Pretax Income	9.41T
Net Income	16.60T
EBITDA	13.65T
EBIT	9.91T
Earnings Per Share (EPS)	9,500.38

Balance Sheet

The company has 8.68 trillion in cash and 16.05 trillion in debt, giving a net cash position of -7,374.24 billion.

Cash & Cash Equivalents	8.68T
Total Debt	16.05T
Net Cash	-7,374.24B
Net Cash Per Share	n/a
Equity (Book Value)	60.57T
Book Value Per Share	34,622.08
Working Capital	13.14T

Cash Flow

In the last 12 months, operating cash flow was 10.77 trillion and capital expenditures -2,695.63 billion, giving a free cash flow of 8.07 trillion.

Operating Cash Flow	10.77T
Capital Expenditures	-2,695.63B
Free Cash Flow	8.07T
FCF Per Share	n/a

Margins

Gross margin is 56.32%, with operating and profit margins of 19.28% and 32.43%.

Gross Margin	56.32%
Operating Margin	19.28%
Pretax Margin	18.32%
Profit Margin	32.43%
EBITDA Margin	26.57%
EBIT Margin	19.28%
FCF Margin	15.72%

Dividends & Yields

This stock pays an annual dividend of 410.69, which amounts to a dividend yield of 0.95%.

Dividend Per Share	410.69
Dividend Yield	0.95%
Dividend Growth (YoY)	51.74%
Years of Dividend Growth	11
Payout Ratio	28.42%
Buyback Yield	0.08%
Shareholder Yield	1.03%
Earnings Yield	5.53%
FCF Yield	2.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.

Last Split Date	Oct 22, 2020
Split Type	Forward
Split Ratio	2

Scores

BCBA:ABT has an Altman Z-Score of 5.6 and a Piotroski F-Score of 6.

Altman Z-Score	5.6
Piotroski F-Score	6